Filtered By:
Source: Heart, Lung and Circulation
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 240 results found since Jan 2013.
Current Prescribing Trends for Atrial Fibrillation Anticoagulation in Australia
Introduction: Management of stroke risk in atrial fibrillation has changed over the last few years with the introduction of novel oral anticoagulants (NOACs) such as Apixaban, Rivaroxaban and Dabigatran. These agents are being increasingly prescribed secondary to the ease of use compared to warfarin which requires regular and ongoing INR monitoring.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: D. Pol, V. Mutha, L. Bittinger Tags: 297 Source Type: research
Stroke in Patients Undergoing Coronary Angiography and Percutaneous Coronary Intervention: Insights From the CADOSA Registry
The objective of this study was to assess the prevalence of periprocedural stroke in contemporary Australian practice.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: L. Halliday, R. Tavella, M. Arstall, D. Chew, M. Worthley, C. Zeitz, J. Beltrame Tags: 464 Source Type: research
Left Atrial Appendage Closure: CT Sizing is Associated with Highly Favourable Procedural Outcomes
Background: Percutaneous left atrial appendage (LAA) closure affords stroke prophylaxis in atrial fibrillation where the risks of anticoagulation are prohibitive. Accurate sizing of the LAA orifice is a key consideration in reducing procedural hazard. CT may be superior to 2D-TOE alone, but there are currently no published outcome data for this strategy to LAA closure workup.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: A. Rajwani, A. Nelson, M. Shirazi, D. Wong, S. Delacroix, R. Chokka, P. Disney, K. Teo, G. Young, S. Worthley Tags: 554 Source Type: research
How Good is Stroke Volume Calculation by the Doppler Continuity Method?
Introduction: Echocardiographic transvalvular stroke volume (SV) calculations are used to quantify regurgitant volume and shunt ratios. Calculations of stroke volume (SV) depend on the accuracy of valve diameter measurement and spectral Doppler velocity recording. We sought to compare how well SV calculated across each of the 4 intracardiac valve correlated with each other.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: J. Stevenson, A. Kwon, G. Scalia Tags: 544 Source Type: research
Cardiovascular Disease, Medications and Heat: What Precautionary Advice is Available?
Global temperatures are rising, increasing the probability of exposure to extreme heat events. Patients with cardiovascular (CV) disease may be at increased risk during extreme heat events, and CV medications may exacerbate this risk through dehydration and electrolyte imbalance- including hyponatraemia. Normal CV adaptation to severe heat stress can involve an increase in cardiac output (CO) by up to 20 L/min and a shift of heated blood from core to peripheral circulation. An inability to increase CO results in impaired heat tolerance and increased susceptibility to heat stroke.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: N. Jeyakumaran, G. Gabb, D. Rowett, R. Tadros Tags: 749 Source Type: research
Perceptions from Cardiac and Stroke Patients of the Information Provided by Health Professionals at Discharge from Hospital (2012-2014)
Introduction: It is essential that patients are provided with education and information on symptom recognition and emergency actions plans at discharge to prevent cardiac and stroke rehospitalisations.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: N. Berry, C. Astley, H. Du, K. Wechkunanukul, J. Tongpeth, P. Wonggom, R. Clark Tags: 707 Source Type: research
Meta-Analysis of Early or Late Surgery for Infective Endocarditis and Associated Stroke
Background: Surgery is recommended for infective endocarditis patients who develop ischaemic stroke, however the optimal timing of surgery remains controversial. In this meta-analysis, we compared the outcomes of early and delayed cardiac surgery for infective endocarditis in this setting.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: T. Wang, M. Wang, J. Pemberton Tags: 684 Source Type: research
Incidence of Thromboembolism and Haemorrhagic Stroke in Patients With Acute Pulmonary Embolism and Atrial Fibrillation: A Population-Linkage Study
Background: Recent studies suggest patients with acute pulmonary embolism (PE) and atrial fibrillation (AF) have increased all-cause mortality compared to patients without AF. However, the morbidity burden remains unknown.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: D. Adikari, J. Lau, V. Chow, L. Kritharides, A. Ng Tags: 634 Source Type: research
Changing Treatment Patterns in Atrial Fibrillation in Australia: Results From the Global Anticoagulation in the Field (GARFIELD) Registry
Background: Oral anticoagulant therapy (OAC) with both non-vitamin K antagonists (NOAC) and vitamin K antagonists (VKA) reduces the risk of stroke in atrial fibrillation (AF). The extent and appropriateness to which these are used in Australia is uncertain.
Source: Heart, Lung and Circulation - July 26, 2016 Category: Cardiology Authors: H. Gibbs, A. Kakkar Tags: 622 Source Type: research
Pulmonary Hypertension due to Radiofrequency Catheter Ablation (RFCA) for Atrial Fibrillation: The Lungs, the Atrium or the Ventricle?
Atrial fibrillation is the most common heart rhythm disorder affecting around 2.5 million people in United States. It is characterised by rapid and irregular beating of both the atria resulting in the similar ventricular response. It is associated with the risk of stroke and heart failure resulting in increased morbidity and mortality [1]. The treatment of atrial fibrillation involves rate control with ant-arrhythmic drugs like beta blockers, digoxin and amiodarone. Cardioversion is recommended in case of haemodynamic instability or after failure of pharmacological therapies.
Source: Heart, Lung and Circulation - July 15, 2016 Category: Cardiology Authors: Isha Verma, Hemantkumar Tripathi, Rutuja Rajanikant Sikachi, Abhinav Agrawal Tags: Review Source Type: research
Non-HDL-C vs. LDL-C in Predicting the Severity of Coronary Atherosclerosis
Atherosclerosis is a complex process involving multiple interfaces among inflammation, hypertension, age, ectopic obesity, diabetes, metabolic syndrome, dyslipidaemias, poor diet, smoking, sedentary lifestyle, impaired immune system, endothelial, vascular, hormonal and coagulation [1 –3]. Dyslipidaemia is a risk factor for coronary artery disease (CAD), stroke, metabolic syndrome (MetS) peripheral artery disease. Early diagnosis and management are key factors in the prevention of atherosclerotic disease and development of cardiovascular events [4,5].
Source: Heart, Lung and Circulation - July 5, 2016 Category: Cardiology Authors: Leonardo Roever, Giuseppe Biondi-Zoccai, Antonio Carlos Palandri Chagas Tags: Editorial Source Type: research
Periprocedural Management of Novel Oral Anticoagulants During Atrial Fibrillation Ablation: Controversies and Review of the Current Evidence
Oral anticoagulation (OAC) has been the cornerstone for the prevention of thromboembolic complications in patients with atrial fibrillation (AF) at significant risk of stroke. Catheter ablation is an established efficacious technique for the treatment of AF. Ameliorating the risk of stroke or transient ischaemic attack (TIA) in patients with AF undergoing ablation requires meticulous planning of pharmacotherapy. The advent of non-vitamin K oral anticoagulants (NOACs) has broadened the therapeutic scope, representing a viable alternative to traditional vitamin K antagonists (VKA) in non-valvular AF.
Source: Heart, Lung and Circulation - June 20, 2016 Category: Cardiology Authors: Hany S. Abed, Vivien Chen, Michael J. Kilborn, Raymond W. Sy Tags: Review Source Type: research
Peri-procedural Management of Novel Oral Anticoagulants During Atrial Fibrillation Ablation: Controversies and Review of the Current Evidence
Oral anticoagulation (OAC) has been the cornerstone for the prevention of thromboembolic complications in patients with atrial fibrillation (AF) at significant risk of stroke. Catheter ablation is an established efficacious technique for the treatment of AF. Ameliorating the risk of stroke or transient ischaemic attack (TIA) in patients with AF undergoing ablation requires meticulous planning of pharmacotherapy. The advent of non-vitamin K oral anticoagulants (NOACs) has broadened the therapeutic scope, representing a viable alternative to traditional vitamin K antagonists (VKA) in non-valvular AF.
Source: Heart, Lung and Circulation - June 20, 2016 Category: Cardiology Authors: Hany S. Abed, Vivien Chen, Michael J Kilborn, Raymond W Sy Tags: Review Source Type: research
Periprocedural Management of Novel Oral Anticoagulants During Atrial Fibrillation Ablation: Controversies and Review of the Current Evidence
Oral anticoagulation (OAC) has been the cornerstone for the prevention of thromboembolic complications in patients with atrial fibrillation (AF) at significant risk of stroke. Catheter ablation is an established efficacious technique for the treatment of AF. Ameliorating the risk of stroke or transient ischaemic attack (TIA) in patients with AF undergoing ablation requires meticulous planning of pharmacotherapy. The advent of non-vitamin K oral anticoagulants (NOACs) has broadened the therapeutic scope, representing a viable alternative to traditional vitamin K antagonists (VKA) in non-valvular AF.
Source: Heart, Lung and Circulation - June 20, 2016 Category: Cardiology Authors: Hany S. Abed, Vivien Chen, Michael J. Kilborn, Raymond W. Sy Tags: Review Source Type: research
Total-Arterial, Aortic No-Touch, Coronary Artery Bypass Grafting using Composite Grafts with Two Internal Mammary Artery Inflows
We describe a method of complete myocardial revascularisation using composite arterial grafts with two internal mammary artery (IMA) inflows. This enables an “aortic no-touch” method, which may reduce the rate of stroke. It also offers the survival advantage associated with the use of two IMAs.
Source: Heart, Lung and Circulation - June 17, 2016 Category: Cardiology Authors: Michael Wilson, James Edelman, Michael Seco, Andrew Sherrah, James Wood, Michael Vallely Source Type: research
